Credibility Rating
High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: CEPI
CEPI is a biological pandemic preparedness organization; marginally relevant to AI safety as a reference model for international coordination on catastrophic risks, but not directly focused on AI.
Metadata
Summary
CEPI is an international organization focused on accelerating vaccine development and securing the world against epidemic and pandemic threats. It funds and coordinates research into vaccines for emerging infectious diseases, supports manufacturing capacity, and works toward a '100 Days Mission' to compress vaccine development timelines. Its work spans biosecurity policy, global health equity, and outbreak preparedness infrastructure.
Key Points
- •CEPI supports over 75 vaccine candidates and platform technologies for epidemic and pandemic threats
- •The IMF estimated COVID-19 cost the global economy $12.5 trillion through 2024, underscoring the stakes of pandemic preparedness
- •CEPI's '100 Days Mission' aims to dramatically shorten vaccine development timelines for future outbreaks
- •Recent initiatives include biosecurity policy publication, AI-driven health cooperation, and Ebola/Lassa/Rift Valley fever vaccine programs
- •CEPI 3.0 investment case outlines a forward-looking strategy to institutionalize pandemic preparedness globally
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Organization | 53.0 |
Cached Content Preview
Home page Latest News Latest News See more Arrow Arrow News Global health leaders join CEPI’s Board and expert groups Blog Ronald Kakeeto: My Fellowship at CEPI Blog Dr Navneet Bichha: My Fellowship at CEPI Blog From ambition to action: Turning CEPI’s strategy into tangible impact Blog Dr Umar Ahmad: My Fellowship at CEPI News CEPI launches global plan to secure the future against epidemic and pandemic threats News Korea runs landmark pandemic simulation exercise to strengthen outbreak readiness Blog Strengthening biosecurity and biosafety oversight: CEPI publishes its first Biosecurity Policy News CEPI and Korea discuss future of AI-driven international health cooperation News CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access Latest News Arrow Arrow See more Read more Read more Read more Read more GraphicCircleDiagonalStripes $12.5 trillion IMF’s estimate cost of the COVID-19 pandemic to the global economy through 2024 GraphicCircleDotsWithBorder Over 75 Number of CEPI-supported vaccine candidates and platform technologies. GraphicCircleExpandingDots 470+ R&D partners collaborating with CEPI Emerging infectious diseases affect us all. They do not respect borders. A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity. CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks. We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem. Find out more Arrow Where to go next Calls for Proposals Read more Careers Read more Procurement tenders Read more Priority pathogens Read more Loading form...
51b045aca2eb9b4d | Stable ID: sid_oJ2J8ABW3L